Last updated: April 10, 2024
Sponsor: Vienna Institute for Research in Ocular Surgery
Overall Status: Active - Recruiting
Phase
N/A
Condition
Eye Disorders/infections
Eye Disease
Vision Loss
Treatment
Pars plana vitrectomy
Clinical Study ID
NCT06358664
Caffeine Vitrectomy
Ages 18-105 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18 or older
- Written informed consent
- No previous cataract surgery in the study eye
- Scheduled small gauge vitrectomy with intraoperative gas tamponade (SF6 or C3F8) dueto retinal detachment or macular hole repair
- No regular caffeine consumption (drinking not more than one cup of a caffeine-containing beverage [e.g. coffee, energy drinks] at a maximum of two days per weekduring the past year)
Exclusion
Exclusion Criteria:
- Intake of systemic or topical corticosteroids within 3 months before study screening
- Increased risk for postoperative cataract development, for example due to oculartrauma in the history
- Severe cataract (LOCS III grading of any cataract form >2) in the study eye at pre-study screening
- Scheduled phacovitrectomy in the study eye
- Participation in any clinical trial three month before study screening
- Ocular surgeries six month before study screening
Study Design
Total Participants: 74
Treatment Group(s): 1
Primary Treatment: Pars plana vitrectomy
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
April 01, 2026
Study Description
Connect with a study center
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna
Vienna, 1140
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.